Frontlight ResearchEarly access
Neuromyelitis optica (NMOSD) trials in United States
10 of 18 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleImpact of a Structured Wellness Behavioral Intervention on Quality of Life in NMOSD
- Where
- New York
- Age
- 18 years and over
- People
- 20
- Run by
- Icahn School of Medicine at Mount Sinai
See details and how to joinNCT06780709 - Phase 2Taking peopleEfgartigimod for the Treatment of Acute Optic Neuritis
- Where
- Boston
- Age
- 18 years and over
- People
- 20
- Run by
- Anastasia Vishnevetsky, MD, MPH
See details and how to joinNCT06453694 - Phase 1Taking peopleA Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
- Where
- Ann Arbor, Cleveland, Columbus, La Jolla, Milwaukee, New York, Omaha, Rochester
- Age
- 18 years and over
- People
- 100
- Run by
- TG Therapeutics, Inc.
See details and how to joinNCT06680037 - Phase 3Taking peopleA Study to Evaluate Pharmacokinetics, Efficacy, Safety, Tolerability, and Pharmacodynamics of Satralizumab in Pediatric Patients With Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder (NMOSD)
- Where
- Denver
- Age
- 2 years to 11 years
- People
- 8 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT05199688 · EU 2023-507817-85-00 - Phase 4Taking peopleRituximab Versus Ravulizumab, Inebilizumab, Satralizumab, and Eculizumab in NMOSD
- Where
- Boston
- Age
- 18 years and over
- People
- 540 worldwide
- Run by
- Massachusetts General Hospital
See details and how to joinNCT07010302 - Phase 1Not yet taking people in United StatesA Safety and Tolerability Study of CC- 97540 (BMS-086353) in Anti-Aquaporin 4 Antibody Positive Neuromyelitis Optica Patients
- Where
- Dallas
- Age
- 18 years to 60 years
- People
- 5
- Run by
- University of Texas Southwestern Medical Center
See details and how to joinNCT07573332 - No phaseEnrolling by invitationAcceptability and Safety of MR-C-014 in Persons With Neuromyelitis Optica Spectrum Disorder
- Where
- Atlanta, Boston
- Age
- 18 years to 70 years
- People
- 30
- Run by
- MedRhythms, Inc.
See details and how to joinNCT06374264 - No phaseTaking peopleStem Cell Ophthalmology Treatment Study II
- Where
- Coral Springs, Westport
- Age
- 18 years and over
- People
- 500 worldwide
- Run by
- MD Stem Cells
See details and how to joinNCT03011541 - Phase 2Taking peopleStudy of Inebilizumab in Pediatric Subjects With Neuromyelitis Optica Spectrum Disorder
- Where
- Boston, Dallas, La Jolla, Loma Linda
- Age
- 2 years to 17 years
- People
- 15 worldwide
- Run by
- Amgen
See details and how to joinNCT05549258 · EU 2023-510007-22-00 - No phaseTaking peoplePerformance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD
- Where
- Baltimore, Boston, Chapel Hill, Evanston, Las Vegas, Los Angeles, Oklahoma City, Sacramento, Tampa, Washington
- Age
- 18 years and over
- People
- 103 worldwide
- Run by
- Ad scientiam
See details and how to joinNCT05566769